/PETS
PETS Stock - PetMed Express, Inc.
Healthcare|Medical - PharmaceuticalsNASDAQ
$3.60-1.37%
$0.05 (-1.37%) • Dec 19
82
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.76
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.89
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+268.1%upside
Target: $13.25
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PETS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.56 – $3.64
TARGET (TP)$13.25
STOP LOSS$3.31
RISK/REWARD1:33.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.77
52W High$5.58
52W Low$1.57
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $226.97M | $281.06M | $256.86M | $273.42M | $303.58M |
| Gross Profit | $69.14M | $78.65M | $71.01M | $76.94M | $84.32M |
| Gross Margin | 30.5% | 28.0% | 27.6% | 28.1% | 27.8% |
| Operating Income | $-1,530,000 | $-8,162,000 | $6.05M | $24.29M | $30.53M |
| Net Income | $-6,271,000 | $-7,464,000 | $5.14M | $18.72M | $23.92M |
| Net Margin | -2.8% | -2.7% | 2.0% | 6.8% | 7.9% |
| EPS | $-0.30 | $-0.37 | $0.25 | $1.05 | $1.53 |
Company Overview
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
1 Bullish0 Neutral/Bearish
Price Targets
$20
Average Target
↑ 455.6% Upside
Now
$20
Low
$20
Average
$20
High
Based on 1 analyst
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| May 25th 2023 | Lake Street | Initiation | Buy | $20 |
Earnings History & Surprises
PETSBeat Rate
18%
Last 17 quarters
Avg Surprise
-193.9%
EPS vs Estimate
Beats / Misses
3/14
Last 12 quarters
Latest EPS
$-1.65
Q4 2025
EPS Surprise History
Q1 24
-900.0%
$-0.10vs$-0.01
Q2 24
-900.0%
$-0.10vs$-0.01
Q3 24
+300.0%
$0.18vs$-0.09
Q4 24
+320.0%
$0.11vs$-0.05
Q1 25
-700.0%
$-0.03vs$0.01
Q4 25
-833.3%
$-0.56vs$-0.06
Q4 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 9, 2026 | $-0.06 | — | — | — |
Q4 2025 | Dec 19, 2025 | — | $-1.65 | — | — |
Q4 2025 | Dec 19, 2025 | — | $-0.34 | — | — |
Q4 2025 | Oct 14, 2025 | $-0.06 | $-0.56 | -833.3% | ✗ MISS |
Q1 2025 | Feb 10, 2025 | $0.01 | $-0.03 | -700.0% | ✗ MISS |
Q4 2024 | Nov 6, 2024 | $-0.05 | $0.11 | +320.0% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $-0.09 | $0.18 | +300.0% | ✓ BEAT |
Q2 2024 | Apr 15, 2024 | $-0.01 | $-0.10 | -900.0% | ✗ MISS |
Q1 2024 | Feb 8, 2024 | $-0.01 | $-0.10 | -900.0% | ✗ MISS |
Q4 2023 | Oct 30, 2023 | $0.09 | $-0.00 | -103.8% | ✗ MISS |
Q3 2023 | Jul 31, 2023 | $0.07 | $-0.04 | -157.1% | ✗ MISS |
Q2 2023 | May 22, 2023 | $0.15 | $0.04 | -73.3% | ✗ MISS |
Q1 2023 | Feb 6, 2023 | $0.20 | $0.02 | -90.0% | ✗ MISS |
Q4 2022 | Nov 7, 2022 | $0.25 | $0.13 | -48.0% | ✗ MISS |
Q3 2022 | Jul 25, 2022 | $0.25 | $0.14 | -44.0% | ✗ MISS |
Q2 2022 | May 9, 2022 | $0.26 | $0.30 | +15.4% | ✓ BEAT |
Q1 2022 | Jan 24, 2022 | $0.30 | $0.21 | -30.0% | ✗ MISS |
Q4 2021 | Oct 25, 2021 | $0.35 | $0.31 | -11.4% | ✗ MISS |
Q3 2021 | Jul 26, 2021 | $0.35 | $0.26 | -25.7% | ✗ MISS |
Q2 2021 | May 3, 2021 | $0.40 | $0.34 | -15.0% | ✗ MISS |
Latest News
PetMed Express jumps on $4.25/share takeover offer from Cardone Ventures
📈 PositiveSeeking Alpha•Dec 16, 2025, 05:19 PM
PetMed Express Shares Resume Trade
➖ NeutralBenzinga•Dec 16, 2025, 05:09 PM
PetMed Express shares are trading higher after the company received an acquisition proposal from Cardone Ventures for approximately $89 million, or $4.25 per share.
📈 PositiveBenzinga•Dec 16, 2025, 05:08 PM
PetMed Express Shares Halted On Circuit Breaker To The Upside, Stock Now Up 23.69%
📈 PositiveBenzinga•Dec 16, 2025, 05:06 PM
PetMed Express Receives Proposal From Cardone Ventures To Acquire The Co For ~$89M, Or $4.25 Per Share
📈 PositiveBenzinga•Dec 16, 2025, 05:06 PM
PetMed Express shares are trading higher after the company announced it received an unsolicited and non-binding acquisition proposal from SilverCape Investments.
📈 PositiveBenzinga•Dec 11, 2025, 03:23 PM
PetMed Express jumps on $4/share takeover offer SilverCape Investments
📈 PositiveSeeking Alpha•Dec 11, 2025, 01:35 PM
SilverCape Announced Non-Binding Proposal to Acquire 100% of PetMed Express' Outstanding Common Stock for $4.00/Share in Cash to Take Company Private -Amended 13D Filing
📈 PositiveBenzinga•Dec 11, 2025, 01:17 PM
PetMed Express Board Approves One-Year Shareholder Rights Plan Through Dec. 2, 2026
📉 NegativeBenzinga•Nov 26, 2025, 09:09 PM
PetMed Express shares are trading lower after the company announced it received a Nasdaq nocompliance notification. Also the company issued a year-over-year decrease in preliminary Q2 net sales results.
📉 NegativeBenzinga•Nov 13, 2025, 02:07 PM
PetMed Express Sees Prelim. Q2 Net Sales $43.4M-$44.5M vs $58M In Prior Year Period
📉 NegativeBenzinga•Nov 13, 2025, 01:06 PM
PetMed Express Receives Nasdaq Delinquency Notification
📉 NegativeBenzinga•Nov 13, 2025, 01:05 PM
PetMed Express CEO and CFO resign; board chair named interim CEO
📉 NegativeSeeking Alpha•Aug 12, 2025, 08:39 PM
PetMed Express delays FQ4 results
📉 NegativeSeeking Alpha•Jun 10, 2025, 09:26 PM
Frequently Asked Questions about PETS
What is PETS's current stock price?
PetMed Express, Inc. (PETS) is currently trading at $3.60 per share. The stock has moved -1.37% today.
What is the analyst price target for PETS?
The average analyst price target for PETS is $13.25, based on 1 analyst.
What sector is PetMed Express, Inc. in?
PetMed Express, Inc. operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the NASDAQ exchange.
What is PETS's market cap?
PetMed Express, Inc. has a market capitalization of $0.07 billion, making it a small-cap company.
Does PETS pay dividends?
No, PetMed Express, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBDSX
Biodesix, Inc.
$6.69
Mkt Cap: $0.0B
CTSO
Cytosorbents Corporation
$0.64
Mkt Cap: $0.0B
FBIO
Fortress Biotech, Inc.
$3.54
Mkt Cap: $0.1B
GNTA
Genenta Science S.p.A.
$1.45
Mkt Cap: $0.0B
ICCM
IceCure Medical Ltd
$0.67
Mkt Cap: $0.0B
MDAI
Spectral AI, Inc.
$1.55
Mkt Cap: $0.0B
MDCX
Medicus Pharma Ltd. Common Stock
$1.69
Mkt Cap: $0.0B
RNTX
Rein Therapeutics Inc.
$1.42
Mkt Cap: $0.0B
TELA
TELA Bio, Inc.
$1.13
Mkt Cap: $0.0B
YI
111, Inc.
$3.69
Mkt Cap: $0.0B
Explore stocks similar to PETS for comparison